Compare Organon Pharma Indonesia Tbk. (SCPI) vs Satria Mega Kencana Tbk. (SOTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Satria Mega Kencana Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Satria Mega Kencana Tbk. trades at Rp600 (market cap 610B, 587.5K 24h volume). The key difference: Satria Mega Kencana Tbk. is far larger — about 5.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SOTS | |
|---|---|---|
Market Cap | 104.4B | 610B |
Volume | — | 587.5K |
Lot | — | 5.88K |
Turnover | — | 347.18M |
Average Price | — | 590.95 |
Value | — | 347.18M |
Indicative Equilibrium Price | — | 600 |
Indicative Equilibrium Volume | — | 5 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Satria Mega Kencana Tbk.
PT Satria Mega Kencana Tbk (the Company) was established based on Notarial Deed No. 62 of Ilmiawan Dekrit Supatmo, S.H., dated June 16, 2004, notary in Jakarta.
Read more on SOTS →
